Form D · Pharmaceuticals

Azelon Pharmaceuticals, Inc.

West Conshohocken, PA · CIK 0001286667

Offering snapshot reported Mar 16, 2012 · SEC filing

Reported sold
$2.42M
Offering amount: $2.42M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 7, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 16, 2012Initial$2,422,000No comparison6SEC filing
Aug 17, 2011Initial$2,793,488No comparison5SEC filing
May 23, 2011Initial$41,666No comparison1SEC filing
May 20, 2010Initial$922,243No comparison6SEC filing
Jun 9, 2009Amendment$9,125,000No comparison16SEC filing
May 8, 2009Amendment$1,500,000No comparisonNot reportedSEC filing
Apr 10, 2009Amendment$1,000,000No comparisonNot reportedSEC filing
Mar 19, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jan 30, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jul 18, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 31, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-175076

Source: Form D, filed Mar 16, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alex Barkas Director
Farah Champsi Director
Jeffrey Courtney Director
Jeff Courtney Director
Colin Goddard Director
Donald Hayden Director
David Krause Executive
Lily Lam Director
Joan Lau Director, Executive
Cynthia Lavoie Director
Brian Mac Donald Director, Executive
Alan Roemer Executive
Jaisim Shah Executive
Joseph Zakrzewski Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Four Tower Bridge, 200 Barr Harbor Drive Suite 400
West Conshohocken, PA, 19428